492456-51-6Relevant articles and documents
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epi
Wissner, Allan,Overbeek, Elsebe,Reich, Marvin F.,Floyd, M. Brawner,Johnson, Bernard D.,Mamuya, Nellie,Rosfjord, Edward C.,Discafani, Carolyn,Davis, Rachel,Shi, Xiaoqing,Rabindran, Sridhar K.,Gruber, Brian C.,Ye, Fei,Hallett, William A.,Nilakantan, Ramaswamy,Shen, Ru,Wang, Yu-Fen,Greenberger, Lee M.,Tsou, Hwei-Ru
, p. 49 - 63 (2007/10/03)
A series of of 6,7-disubstituted-4-anilinoquinoline-3-carbonitrile derivatives that function as irreversible inhibitors of EGFR and HER-2 kinases have been prepared. These inhibitors have, at the 6-position, butynamide, crotonamide, and methacrylamide Mic